Status:
RECRUITING
Child to Adult Neurodevelopment in Gene Expanded Huntington's Disease
Lead Sponsor:
Peggy C Nopoulos
Collaborating Sponsors:
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Huntington's Disease
Eligibility:
All Genders
6-30 years
Brief Summary
Huntington's Disease (HD) is an autosomal dominant disease manifested in a triad of cognitive, psychiatric, and motor signs and symptoms. HD is caused by a triplet repeat (CAG)expansion in the gene Hu...
Eligibility Criteria
Inclusion
- Family history of Huntington's Disease
- Age 6-30 years
- Age-appropriate knowledge of HD and personal risk
Exclusion
- Metal in body, including braces
- History of head trauma, brain tumor, seizures, epilepsy
- History of major surgery and/or significant ongoing medical issue(s)
Key Trial Info
Start Date :
July 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 31 2026
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT01860339
Start Date
July 1 2005
End Date
August 31 2026
Last Update
December 23 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California Davis
Sacramento, California, United States, 95817
2
University of Iowa Hospitals and Clinics, Department of Psychiatry
Iowa City, Iowa, United States, 52242
3
Columbia University Medical Center
New York, New York, United States, 10027
4
Children's Hospital of Philadelphia with the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19146